Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal SENMEA
Wahyudi, Aguna Anugraha
Unknown Affiliation
Decision Sciences, Operations Research & Management Economics, Econometrics & Finance Social Sciences

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
ANALISIS PERBANDINGAN KINERJA KEUANGAN ANTARA PERUSAHAAN FARMASI MILIK NEGARA (BUMN) DENGAN PERUSAHAAN FARMASI MILIK SWASTA (BUMS) YANG TERDAFTAR DI BURSA EFEK INDONESIA (PERIODE 2015-2019) Wahyudi, Aguna Anugraha; Hermawan, Hendy
Prosiding Seminar Nasional Manajemen, Ekonomi dan Akuntansi Vol. 6 No. 1 (2021): PROSIDING SEMINAR NASIONAL MANAJEMEN, EKONOMI DAN AKUNTANSI 2021
Publisher : Universitas Nusantara PGRI Kediri

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

This study aims to examine the comparison of financial performance between state-owned companies and privately-owned companies in the pharmaceutical industry listed on the Indonesia Stock Exchange for the 2015-2019 period. The variables used to compare financial performance are Current Ratio (CR), Net Profit Margin (NPM), Operating Profit Margin (OPM), Return On Asset Ratio (ROA). This type of research is a comparative study. The research sample consisted of 11 companies consisting of 3 state-owned pharmaceutical companies and 8 private pharmaceutical companies. The sample was selected using the purposive sampling method. The research data were analyzed with SPSS version 26 using parametric statistical tests, namely the independent sample t-test. The results of the study using the two-average difference test showed that there was no significant difference in financial ratios consisting of OPM, NPM, and ROA between state-owned pharmaceutical companies and private-owned pharmaceutical companies listed on the Indonesia Stock Exchange during the study period. While the CR there is a significant difference between the two in the study period. Overall, the financial performance of privately-owned pharmaceutical companies is better than that of state-owned pharmaceutical companies listed on the Indonesia Stock Exchange in the study period
Co-Authors Hendy Hermawan